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Background: The prevalence of chronic obstructive pulmonary disease (COPD) is similar in Japan and China and is
increasing due to high rates of smoking in these countries. Reducing COPD is an important public health issue. The
goals of this study were to verify the reliability and validity of the Japanese version of the COOP/WONCA charts, a
tool for measuring health status, and to examine the qualitative differences in health status between Japanese and
Chinese patients with COPD and between these patients and healthy subjects.
Methods: From 2008 to 2011, we examined the factors affecting the health status of Japanese and Chinese
populations living in six cities. Participants were patients with COPD staged according to the Global Initiative for
Chronic Obstructive Lung Disease (GOLD) criteria (140 Japanese, 201 Chinese) and healthy subjects (243 Japanese,
199 Chinese), all 50 to 79 years old. Health status was measured by using the COOP/WONCA charts, and basic
information such as smoking status and medical history was reported by the participants.
Results: The Japanese and Chinese versions of the COOP/WONCA charts were shown to be reliable and valid by
test-retest, comparison with the SF-36 and respiratory symptoms, and correlation of results obtained from patients
and their physicians. Stepwise multiple regression analyses demonstrated that “Physical fitness”, “Daily activities”,
and “Social activities” were predicted by COPD status and/or respiratory symptoms; “Feelings” by nationality and
respiratory symptoms; “Pain” by sex and respiratory symptoms; and “Overall health” by nationality. When the COOP/
WONCA scores were stratified by nationality, age, sex, and COPD status, the difference of each score between the
patients and healthy subjects was larger for the Chinese subjects than for the Japanese. The physical, psychosocial
activities, and pain scores increased significantly as COPD status worsened in Chinese subjects, whereas these
scores were not affected by sex, age, or COPD status for Japanese subjects. Brinkman index and use of smoky fuel
indoors affected the COOP/WONCA scores in Chinese patients but not in Japanese patients.
Conclusions: The Japanese COOP/WONCA charts are reliable and valid. COPD more severely affected the health
status of Chinese participants than of Japanese participants. These results suggest that countermeasures against
insufficient health care and smoky environments may improve the health status of Chinese patients with COPD.
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Chronic obstructive pulmonary disease (COPD) is the
fourth leading cause of death in the world. The main
risk factors for COPD are cigarette smoking [1] and
aging [2], and its prevalence and related mortality are
expected to increase as the population ages [3]. There-
fore, development of a strategy to prevent and treat
COPD is an urgent issue in public health. Because the
increased numbers of COPD patients represent an eco-
nomic and social burden [4], there is a need for counter-
measures in Asia where the air pollution is severe [5],
the population is aging rapidly, and smoking rates are
high.
Smoking rates are higher in Asia than in the Western
developed countries. The smoking rate in Japan is 23.4%
(38.2% for men and 10.9% for women) [6], although it
has declined rapidly in response to a governmental cam-
paign [7]. According to the World Health Organization
[6], the smoking rate in China is 26.1% (52.1% for men
and 2.3% for women). Similarly, a study of the general
population of China aged 15 years and older reported
the smoking rate to be 27.7% (52.1% for men and 2.3%
for women) [8]. The prevalence of COPD is 10.9%
(16.4% for men and 5.0% for women) in Japan [9] and
8.2% (12.4% for men and 5.1% for women) in China
[10]. Another study reported a prevalence of 9.3% for
men and 5.1% for women among 602 subjects from the
general population of Guangzhou, China [11].
The smoking rate is currently decreasing in Japan,
whereas in China the smoking rate is increasing. The
prevalence of COPD and mortality from the disease are
expected to increase due to prolonged life expectancy.
The economic burden of treatment for COPD [12] and
the social burden of the loss of disability-adjusted life
years due to COPD [13] are also increasing because the
prevalence of COPD, which is a slowly progressive
chronic disease and puts patients at increased risk of in-
fectious disease [14], is greatly elevated in those who are
40 years or older. However, little is known about the
health status of older patients with COPD in Asia, and
no study has compared the health status of Japanese
and Chinese populations, who live with completely dif-
ferent medical systems, environments, and other patient
circumstances.
International comparative studies using questionnaires
must consider the cultural background of participants,
such as language and customs. In addition, for research
targeting a geriatric subject, a simplified questionnaire is
required that is written in short, easy-to-understand
sentences; is visually apparent; and can be completed in
a short time. The COOP/WONCA charts, which consist
of seven simple questions with associated drawings, were
developed by the World Organization of National Col-
leges, Academies and Academic Associations of GeneralPractitioners/Family Physicians (WONCA) to assess the
health status of patients visiting primary care physicians.
The reliability and validity of the English [15] and Chinese
[16] versions have been verified. However, the Japanese
version of the COOP/WONCA charts has been examined
only for schoolchildren and not for adults [17-19]. Only a
few studies have examined the health status of patients
with COPD by using the COOP/WONCA charts in West-
ern countries and China, and few studies have evaluated
the health status of older patients with COPD, although
one international comparative study has used the COOP/
WONCA charts [20]. Therefore, we performed this study
to verify the reliability and validity of the Japanese version
of the COOP/WONCA charts and to examine the qualita-
tive differences of health status between Japanese and
Chinese patients with COPD ages 50-79 years and be-
tween these patients and healthy subjects.
Methods
Subjects
The survey was conducted in six cities in Japan and
China from 2008 to 2011. The sites are Shimonoseki-shi
(Yamaguchi prefecture), Goto-shi (Nagasaki prefecture),
and Kumamoto-shi (Kumamoto prefecture) in south-
western Japan and Beijing, Shanghai, and Ulanhot (Inner
Mongolia) in China. Patients ages 50-79 years visiting
outpatient clinics and healthy subjects having medical
checkups at health care centers were enrolled. This
study was approved in advance by the Clinical Ethics
Committee of Kurume University, Fukuoka, Japan. The
objectives and other details of the study were explained
to the subjects, and their written informed consent was
obtained.
Pulmonologists examined the pulmonary function of
the patients with COPD in hospitals or clinics, diag-
nosed respiratory disease, and determined COPD stage
(I, II, III, or IV) using the Global Initiative for Chronic
Obstructive Lung Disease (GOLD) criteria [21]. Patients
with home oxygen therapy were excluded. Pulmonary
function of healthy subjects was tested in health care
centers. Healthy subjects did not have dyslipidemia or
respiratory, circulatory, gastrointestinal, or endocrine
disease.
The questionnaire is a self-administered booklet that
consists of requests for basic information, four questions
related to respiratory symptoms (“cough caused by the
weather”, “sputum without infectious disease”, “sputum
in the morning”, and “wheezing”), and the COOP/
WONCA charts. Medical staff distributed and collected
the questionnaires at the hospitals and clinics. Health
care centers mailed the questionnaires to healthy partici-
pants beforehand and collected them at health checkups.
Permission to use the Japanese version of SF-36v2 (SF-36)
Additional file 1 was obtained from Quality Metric (New
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the COOP/WONCA charts Additional file 2, permission
was obtained from the Japan Primary Care Association
and Dr. Cindy Lam, who developed the Chinese version of
the COOP/WONCA charts. The responses to the COOP/
WONCA charts are scored on a five-point ordinal scale
ranging from 1 to 5 (1 = best, 5 = worst). The responses
to the SF-36 are on three-, five-, or six-point ordinal scales,
from which we calculated the eight subscales from 0 to
100 points (max = 100) as instructed in the manual [22].
Analytical methods
All completed questionnaires were assigned identifica-
tion numbers after collection. All cases missing values in
the questionnaire were removed from the data set before
the statistical analyses were performed. Data were ana-
lyzed by t-test, chi-square test, correlation analysis, and
a multiple-regression analysis by using JMP Ver.10.0
(SAS Institute, Cary, NC, USA) and SPSS Ver.17 (IBM,
Armonk, NY, USA). Probability less than 0.005 was con-
sidered to be statistically significant.
Results
Characteristics of participants
Study subjects included 140 COPD patients with GOLD
status I-IV in Japan and 201 in China, as well as 243
healthy subjects in Japan and 199 in China (Table 1).
The ratio of men to women was 3:2 for the Japanese and
1:1 for the Chinese group. Approximately 40% of the
males of both nationalities had white-collar jobs, and ap-
proximately 27% (Japanese) and 37% (Chinese) had
blue-collar jobs. Approximately 33% of Japanese men
and 20% of Chinese men were retired, as was expected
because this study was targeted to older individuals. The
proportion of housewives was high among both popula-
tion groups. In addition, Chinese women were more likely
to have blue-collar jobs than were Japanese women.
COPD status was determined in accordance with the
GOLD criteria. Among male participants, 42.2% of
Japanese and 62.5% of Chinese were patients with COPD;
among female participants, 28.1% of Japanese and 37.0%
of Chinese were patients with COPD (Table 1). The per-
centages of current and ex-smokers among healthy sub-
jects was 78.2% of Japanese men, 39.7% of Chinese men,
12.7% of Japanese women, and 2.5% of Chinese women.
Among the healthy subjects, more Japanese than Chinese
were current or ex-smokers, regardless of sex. A higher
proportion of Japanese than of Chinese male patients had
both smoking experience and COPD; however, the pro-
portion of female COPD patients with smoking experience
was higher in the Chinese than in the Japanese. A higher
percentage of patients with COPD than of healthy subjects
had a Brinkman Index (BI; number of cigarettes smoked
per day times smoking years) greater than 500. AllJapanese participants used gas or electricity for cooking
and heating, whereas 21%-25% of Chinese participants
used fuel that causes indoor air pollution, such as coal,
which was the most common heating source. Some partic-
ipants in Ulanhot, Inner Mongolia, used wood, the dried
dung of sheep, or dried corncobs as heating sources.
The reliability and validity of the Japanese and Chinese
versions of the COOP/WONCA charts
We examined the correlation between COOP/WONCA
chart scores and SF-36 subscale scores in matched sub-
jects (same sex and age). For participants of both nation-
alities, the “Physical fitness”, “Social activities”, “Overall
health”, and “Pain” COOP/WONCA charts were highly
correlated with the SF-36 subscales “Physical function-
ing”, “Role emotional”, “General health perceptions”, and
“Bodily pain,” respectively (Table 2). The “Feelings” and
“Daily activities” COOP/WONCA chart items correlated
with different subscales of SF-36, depending on national-
ity. In the Japanese group, the COOP/WONCA scores
of “Feelings” and “Daily activities” were correlated with
the scores of “Mental health” and “Vitality” of the SF-36
subscales. In contrast, in the Chinese group, the COOP/
WONCA scores of “Feelings” and “Daily activities”
showed the highest correlation with “General health per-
ceptions” and “Bodily pain” of the SF-36 subscales. In
both groups, the correlations between the COOP/
WONCA charts and the related subscales of the SF-36
were relatively high except for “Change in health”. Test-
retest reliability was examined with 104 Japanese and 22
Chinese participants, with a one-month interval between
tests. The intraclass correlation coefficients (ICC) ranged
from 0.696 to 0.890 in the Japanese subjects and from
0.657 to 0.817 in the Chinese subjects, except for
“Change in health” (data not shown), demonstrating that
both the Japanese and Chinese versions of the COOP/
WONCA charts had excellent reliability.
Next, to assess the external validity of the COOP/
WONCA chart, we examined the correlation of COOP/
WONCA chart scores between Japanese and Chinese
patients with COPD and their physicians, matched with
age, sex, and COPD status. The scores for all of the
items, except for “Pain” in the Japanese group, were
highly correlated between the physicians and the pa-
tients (Table 3). For both nationalities, the scores
assigned by the physicians were higher (worse) than
those assigned by the patients, except for “Pain” in the
Japanese group and “Daily activities” in the Chinese group.
The difference of the “Pain” score between the physicians
and patients was relatively large (mean, –0.46) in the Japa-
nese population, indicating that the patients felt more se-
vere pain than their physicians recognized.
We also examined the correlation between COOP/
WONCA chart scores and single predictive variables
Table 1 Characteristics of participants
Male (n = 438) Female (n = 345)
Chi-squared Chi-squared
Japanese Chinese Japanese Chinese
Population (n (%)) 230 (52.5) 208 (47.5) 153 (44.3) 192 (55.7)
Age (y) (mean ± SD) 62.77 ± 8.53 65.84 ± 7.69 60.10 ± 7.62 63.86 ± 8.46
Body Mass Index (mean ± SD) 23.06 ± 3.30 23.61 ± 3.86 22.37 ± 3.06 24.02 ± 3.88
Job (n (%)) White collar 92 (51.4) 87 (48.6) 0.0056 50 (50.0) 50 (50.0) 0.0245
Blue collar 63 (45.3) 76 (54.7) 33 (33.0) 67 (67.0)
Housewife 0 (−) 0 (−) 70 (48.3) 75 (51.7)
Retired 75 (64.1) 42 (35.9) 0 (−) 0 (−)
Missing 0 (0.0) 3 (100.0) 0 (−) 0 (−)
Group (n (%)) Healthy 133 (63.0) 78 (37.0) < 0.0001 110 (47.6) 121 (52.4) 0.0817
COPD 97 (42.7) 130 (57.3) 43 (37.7) 71 (62.3)
Cigarette smoking (n (%)) Healthy subjects
Current smoker 43 (66.2) 22 (33.8) < 0.0001 9 (75.0) 3 (25.0) 0.0045
Ex-smoker 61 (87.1) 9 (12.9) 5 (100.0) 0 (0.0)
Non smoker 29 (43.3) 38 (56.7) 96 (45.7) 114 (54.3)
Missing 0 (0.0) 9 (100.0) 0 (0.0) 4 (100.0)
COPD patients
Current smoker 13 (28.3) 33 (71.7) 0.0007 2 (25.0) 6 (75.0) 0.0041
Ex-smoker 67 (52.3) 61 (47.7) 6 (22.2) 21 (77.8)
Non smoker 17 (40.5) 25 (59.5) 35 (50.0) 35 (50.0)
Missing 0 (0.0) 11 (100.0) 0 (0.0) 9 (100.0)
Brinkman Index (n (%)) Healthy subjects
0 29 (43.3) 38 (56.7) < 0.0001 96 (45.7) 114 (54.3) 0.0064
0 < BI 500 44 (64.7) 24 (35.3) 13 (81.3) 3 (18.8)
BI > 500 60 (89.6) 7 (10.4) 1 (100.0) 0 (0.0)
Missing 0 (0.0) 9 (100.0) 0 (0.0) 4 (100.0)
COPD patients
0 17 (40.5) 25 (59.5) < 0.0001 35 (50.0) 35 (50.0) 0.0036
0 < BI 500 17 (27.9) 44 (72.1) 4 (28.6) 10 (71.4)
BI > 500 63 (55.8) 50 (44.2) 4 (19.0) 17 (81.0)
Missing 0 (0.0) 11 (100.0) 0 (0.0) 9 (100.0)
Heating sources (n (%)) Biomass, Coal, Animal dung 0 (0.0) 52 (100.0) < 0.0001 0 (0.0) 41 (100.0) < 0.0001
Gas, Electric, Steam 230 (60.1) 153 (39.9) 153 (50.7) 149 (49.3)
Missing 0 (0.0) 3 (100.0) 0 (0.0) 2 (100.0)
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ber of respiratory symptoms, and COPD status). For the
Japanese group, “Physical fitness”, “Feelings”, and “Social
activities” were highly correlated with age, and five items
(“Physical fitness”, “Feelings”, “Social activities”, “Change
in health”, and “Overall health”) were correlated with
the number of respiratory symptoms and COPD status
(Table 4, upper panel). For the Chinese group, “Physical
fitness” and “Overall health” were correlated with age,
the rest of the scores except for “Change in health” werecorrelated with both BI and the number of respiratory
symptoms, and all scores were highly correlated with
COPD status (Table 4, lower panel). Moreover, “Daily
activities” and “Social activities” were correlated signifi-
cantly with heating sources.
Stepwise multiple regression analyses to determine the
predictive variables affecting each item of the health status
To determine which variables predict the COOP/
WONCA chart scores, we performed stepwise multiple
Table 2 Correlation between the COOP/WONCA charts and SF-36 subscales in age and sex matched Japanese and
Chinese subjects
Japanese (n = 26) COOP/WONCA chart
Physical fitness Feelings Daily activities Social activities Change in health Overall health Pain
SF-36 subscale
Physical functioning −0.508 −0.180 −0.344 −0.505 −0.312 −0.151 −0.424
Role physical −0.368 −0.046 −0.262 −0.569 −0.031 −0.288 −0.237
Bodily pain −0.176 −0.141 −0.184 −0.074 −0.287 −0.278 −0.797
General health perceptions −0.196 −0.235 −0.367 −0.497 −0.022 −0.472 −0.266
Vitality −0.360 −0.608 −0.632 −0.510 −0.102 −0.241 −0.441
Social functioning −0.492 −0.484 −0.597 −0.668 −0.000 −0.397 −0.238
Role emotional −0.392 −0.191 −0.332 −0.688 −0.159 −0.263 −0.258
Mental health −0.304 −0.674 −0.454 −0.545 −0.192 −0.238 −0.465
Chinese (n = 26) COOP/WONCA chart
Physical fitness Feelings Daily activities Social activities Change in health Overall health Pain
SF-36 subscale
Physical functioning −0.847 −0.872 −0.793 −0.758 −0.097 −0.676 −0.866
Role physical −0.695 −0.831 −0.789 −0.780 −0.316 −0.675 −0.883
Bodily pain −0.617 −0.875 −0.882 −0.843 −0.456 −0.656 −0.905
General health perceptions −0.773 −0.912 −0.876 −0.848 −0.283 −0.720 −0.899
Vitality −0.528 −0.735 −0.605 −0.632 −0.014 −0.537 −0.745
Social functioning −0.469 −0.741 −0.739 −0.759 −0.333 −0.487 −0.726
Role emotional −0.654 −0.826 −0.859 −0.869 −0.449 −0.712 −0.903
Mental health −0.414 −0.673 −0.591 −0.638 −0.170 −0.428 −0.672
Data are presented as Pearson’s correlation coefficients.
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WONCA chart item as dependent variables and popula-
tion group, sex, age, COPD status, the number of respira-
tory symptoms, BI, and heating sources as predictive
variables. The variance inflation factors were 2 or less, and
the all F-values resulting from the analyses of variance
were significant at P < 0.0001. The predictive variables
with standardized partial regression coefficients > 0.2 were
COPD status for “Physical fitness” and “Daily activities”,
COPD status and the number of respiratory symptoms for
“Social activities”, nationality and the number of respiratory
symptoms for “Feelings”, sex and the number of respiratory
symptoms for “Pain”, nationality for “Overall health”, and
heating sources for “Change in health” (Table 5).
Comparison of health status between groups
(nationality, sex, age, COPD status)
Using the results obtained from the stepwise multiple re-
gression analyses; we compared the COOP/WONCA
chart scores between the groups stratified by nationality,
sex, age, and COPD status (moderate, severe). Differ-
ences in the scores between healthy subjects and pa-
tients with COPD were small in the Japanese group;
health status was not affected by sex, age, or COPD sta-
tus except for the group of the patients with moderateCOPD aged 70–79 years (Table 6, upper panel). In con-
trast, in the Chinese group, differences were large be-
tween healthy subjects and patients with COPD, and the
scores of all items except for “Change in health” tended
to worsen in association with the progression of COPD
in the Chinese group. There were no effects of sex or
age between healthy subjects and the patients with mod-
erate or severe COPD. Although a few scores were
worse in older subjects and differed between the sexes,
these results did not show any pattern.
Discussion
Validity and reliability of the Japanese and Chinese
versions of COOP/WONCA charts
The Chinese version of the COOP/WONCA charts [16]
had already been shown to be reliable and valid for ner-
vous system diseases, orthopedic disease, cancer, and
strokes in China. Patients’ acceptance of the test is high,
and the test is useful for the doctors who are evaluating
them [16,23]. Although the Japanese version of the
COOP/WONCA charts has been used to measure quality
of life in the field of ophthalmology [24], and as a health
survey and to measure quality of life in pediatrics [25,26],
its reliability and validity have not been fully confirmed in
an adult Japanese population. In our study, we enrolled
Table 4 Spearman’s rank correlation coefficient between COO
Japanese (n = 370) Physical fitness Feelings Daily ac
Age 0.244** −0.175* 0.021
Sex 0.093 0.065 −0.045
Body Mass Index 0.007 −0.007 −0.064
Brinkman index −0.031 −0.036 0.030
Heating sources - - -
Number of respiratory symptoms 0.175* −0.010 0.095
COPD status 0.213** −0.202** 0.011
Chinese (n = 400) Physical fitness Feelings Daily ac
Age 0.228** 0.069 0.066
Sex −0.009 −0.020 −0.091
Body Mass Index −0.070 −0.034 −0.086
Brinkman index 0.257** 0.308** 0.396**
Heating sources 0.009 0.100 0.157*
Number of respiratory symptoms 0.368** 0.547** 0.653**
COPD status 0.452** 0.575** 0.738**
*: P<0.005, **: P<0.001.
Table 3 Correlation of COOP/WONCA chart scores
assigned by the patients and their physicians in age and








Japanese (n = 13)
Physical fitness 0.801 4.23 ± 0.73 4.00 ± 1.29
Feelings 0.617 1.85 ± 0.80 1.54 ± 0.52
Daily activities 0.722 2.15 ± 0.99 1.92 ± 0.95
Social activities 0.527 1.23 ± 0.44 1.08 ± 0.28
Change in health 0.815 3.15 ± 0.38 3.00 ± 0.82
Overall health 0.850 3.00 ± 0.71 2.77 ± 0.83
Pain 0.237 1.46 ± 0.78 1.92 ± 1.12
Chinese (n = 13)
Physical fitness 0.965 3.85 ± 0.90 3.77 ± 1.01
Feelings 0.941 2.00 ± 0.82 1.92 ± 0.76
Daily activities 0.974 2.54 ± 1.20 2.62 ± 1.12
Social activities 0.953 2.00 ± 0.91 1.92 ± 0.86
Change in health 0.980 3.31 ± 1.38 3.23 ± 1.30
Overall health 0.826 3.92 ± 0.95 3.77 ± 0.93
Pain 0.978 2.38 ± 1.26 2.31 ± 1.32
Data in scores and differences are presented as mean ± SD.
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was patients with COPD, and the incidence of COPD in-
creases with age. We verified the reliability and validity of
the COOP/WONCA chart in Japanese and Chinese
groups of healthy subjects and patients with COPD.
The “Feelings” and “Daily activities” COOP/WONCA
charts showed high correlation with the mental compo-
nent scores of the SF-36 in the Japanese population and
the physical component scores of the SF-36 in the Chinese
population. “Change in health”, which asks about changes
in health status compared with that of the previous two
weeks, was correlated with the physical component of
SF-36 in both groups, but most with “physical function-
ing” in the Japanese group and most with “bodily pain”
in the Chinese group. Other than these differences, the
correlation of the COOP/WONCA charts and the sub-
scales of SF-36 were consistent between the Japanese
and Chinese groups. These results suggest that the Japa-
nese and Chinese versions of the COOP/WONCA
charts are appropriate for evaluating the health status of
older healthy subjects and patients with COPD. The re-
producibility of the COOP/WONCA charts, except for
“Change in health”, was confirmed: in the test-retest, the
ICC of each item was in the range of 0.657 to 0.890 in
both the Japanese and Chinese populations.
We evaluated external validity and sensitivity by cor-
relating the patient's evaluation with their doctor’s evalu-
ation using the same COOP/WONCA charts, the
number of respiratory symptoms associated with COPD,
and the COPD status. After the subjects were matchedP/WONCA chart scores and subjects’ parameters
COOP/WONCA chart
tivities Social activities Change in health Overall health Pain
−0.203** −0.120 −0.043 −0.108
0.029 −0.089 −0.101 0.173*
−0.023 −0.026 −0.084 0.003
−0.057 0.015 0.141 −0.112
- - - -
−0.009 −0.047 0.105* 0.089
−0.191** −0.148* 0.018 −0.037
COOP/WONCA chart
tivities Social activities Change in health Overall health Pain
0.104 0.073 0.174* 0.088
−0.106 0.026 −0.036 0.088
−0.055 0.041 −0.130 −0.041
0.328** −0.030 0.253** 0.206**
0.146* −0.132 0.023 0.139
0.616** 0.098 0.398** 0.407**
0.681** 0.200** 0.484** 0.429**
Table 5 Multiple-regression analyses of COOP/WONCA chart scores (dependent variables) and predictive variables
Dependent variables Predictive variables β P R2
Adjusted R2
Physical fitness Population group 0.125 < 0.001
Age 0.152 < 0.001 0.245
Sex 0.132 < 0.001 0.240
COPD status 0.252 < 0.001
Number of respiratory symptoms 0.161 < 0.001
Heating sources




Number of respiratory symptoms 0.318 < 0.001
Heating sources
Daily activities Population group
Age 0.107 0.020 0.257
Sex 0.254
COPD status 0.396 < 0.001
Number of respiratory symptoms 0.184 < 0.001
Heating sources
Social activities Population group
Age −0.114 0.002 0.204
Sex 0.201
COPD status 0.264 < 0.001
Number of respiratory symptoms 0.258 < 0.001
Heating sources




Number of respiratory symptoms
Heating sources −0.204 < 0.001
Overall health Population group 0.216 < 0.001
Age 0.199
Sex 0.195
COPD status 0.197 < 0.001
Number of respiratory symptoms 0.172 < 0.001
Heating sources
Pain Population group −0.185 < 0.001
Age 0.117
Sex 0.207 < 0.001 0.112
COPD status 0.129 0.005
Number of respiratory symptoms 0.234 < 0.001
Heating sources
n = 737.
Population group (Japanese: 0, Chinese: 1) Sex (male: 0, female: 1), Heating sources (Biomass, coal, Animal dung: 1, Gas, Electric, Steam: 0) Number of respiratory
symptoms (0–4), COPD status (health: 0, GOLD LV 1–4: 1–4).
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Table 6 Comparison of COOP/WONCA chart scores between the Japanese and Chinese groups, stratified by race, sex,
age, and COPD status
Japanese COOP/WONCA chart











Healthy subjects 50-59 Male 90 2.12 ± 0.92 2.21 ± 0.85 1.71 ± 0.84 1.52 ± 0.72 2.97 ± 0.32 2.78 ± 0.58 2.36 ± 0.88
Female 77 2.86 ± 0.96 2.27 ± 0.77 1.70 ± 0.86 1.52 ± 0.58 2.90 ± 038 2.69 ± 0.65 2.68 ± 0.85
60-69 Male 35 2.80 ± 1.05 2.26 ± 1.01 1.77 ± 0.97 1.40 ± 0.74 2.91 ± 0.37 2.51 ± 0.74 1.94 ± 0.80
Female 27 3.07 ± 1.07 1.96 ± 0.85 1.70 ± 0.82 1.30 ± 0.82 2.96 ± 0.365 2.78 ± 0.70 2.33 ± 1.07
70-79 Male 8 3.00 ± 1.20 2.13 ± 0.99 1.75 ± 0.71 1.75 ± 0.71 3.13 ± 0.35 3.13 ± 0.64 2.50 ± 0.53
Female 6 2.17 ± 0.41 2.50 ± 1.52 1.50 ± 0.84 1.33 ± 0.52 3.00 ± 0.00 2.17 ± 0.75 2.50 ± 0.84
Patients with
moderate COPD
50-59 Male 3 3.00 ± 0.00 2.00 ± 0.00 1.67 ± 1.15 1.00 ± 0.00 3.00 ± 0.00 3.00 ± 1.00 2.67 ± 0.58
Female 4 2.50 ± 0.58 2.50 ± 1.29 1.50 ± 1.00 2.25 ± 1.50 3.25 ± 0.50 2.75 ± 1.26 3.25 ± 0.50
60-69 Male 21 2.57 ± 0.93 1.76 ± 0.94 1.71 ± 1.01 1.38 ± 0.86 2.95 ± 0.50 2.81 ± 0.87 2.24 ± 1.00
Female 15 2.93 ± 1.39 2.13 ± 0.92 1.87 ± 1.13 1.47 ± 1.13 2.67 ± 0.82 2.47 ± 0.83 2.40 ± 1.18
70-79 Male 29 3.21 ± 1.50 1.83 ± 0.85 1.93 ± 1.03 1.17 ± 0.47 2.86 ± 0.83 2.76 ± 0.91 2.41 ± 1.24
Female 17 2.82 ± 1.47 1.94 ± 0.90 1.41 ± 0.71 1.12 ± 0.33 2.00 ± 1.00 2.24 ± 0.83 2.82 ± 1.13
Patients with
severe COPD
50-59 Male 1 3.00 3.00 2.00 3.00 3.00 3.00 4.00
Female 0 - - - - - - -
60-69 Male 8 3.38 ± 1.30 1.13 ± 0.35* 1.63 ± 1.19 1.00 ± 0.00 2.50 ± 0.93 2.63 ± 0.92 2.00 ± 1.20
Female 3 3.00 ± 1.00 2.33 ± 1.15 2.00 ± 1.00 1.33 ± 0.58 3.33 ± 0.58 3.33 ± 0.58 3.00 ± 1.00
70-79 Male 23 3.70 ± 1.36 1.87 ± 0.97 1.91 ± 1.12 1.30 ± 0.63 2.87 ± 0.76 2.83 ± 0.65 2.00 ± 1.04
Female 3 3.33 ± 1.53 1.00 ± 0.00 1.33 ± 0.58 1.00 ± 0.00 2.33 ± 1.15 2.67 ± 0.58 1.67 ± 1.15
Chinese COOP/WONCA chart











Healthy subjects 50-59 Male 14 2.07 ± 1.27 1.21 ± 0.85 1.07 ± 0.27 1.00 ± 0.00 2.93 ± 0.27 2.43 ± 0.94 1.79 ± 1.12
Female 51 2.51 ± 0.18 1.31 ± 0.47 1.20 ± 0.49 1.14 ± 0.53 3.02 ± 0.14 2.65 ± 1.00 1.78 ± 1.06
60-69 Male 32 2.03 ± 1.12# 1.31 ± 0.69 1.13 ± 0.42 1.09 ± 0.39 2.94 ± 0.50 2.38 ± 0.91 1.41 ± 0.76
Female 32 3.00 ± 1.37 1.44 ± 0.50 1.31 ± 0.64 1.19 ± 0.40 3.00 ± 0.51 2.88 ± 1.13 1.97 ± 1.06
70-79 Male 32 3.03 ± 1.12 1.16 ± 0.45 1.03 ± 0.18 1.06 ± 0.25 2.94 ± 0.44 2.88 ± 0.83 1.59 ± 0.84#
Female 38 3.74 ± 1.20 1.24 ± 0.43 1.13 ± 0.34 1.13 ± 0.34 3.05 ± 0.46 3.32 ±0.99 2.39 ±1.10
Patients with
moderate COPD
50-59 Male 16 3.56 ± 0.81** 1.75 ± 0.86 2.19 ± 0.91 1.62 ± 0.72 2.56 ± 1.09 3.50 ± 0.63* 1.94 ± 0.93
Female 18 3.44 ± 0.31 2.00 ± 0.97** 2.33 ± 0.84** 1.83 ± 0.71** 2.61 ± 0.98 3.44 ± 0.92 2.50 ± 1.04
60-69 Male 21 3.52 ± 0.87** 1.90 ± 0.83 1.67 ± 0.66 1.76 ± 0.83 2.71 ± 1.10 3.19 ± 1.08* 2.33 ± 0.91*
Female 17 3.41 ± 0.62 2.35 ± 0.49** 2.29 ± 0.69** 2.24 ± 0.66 3.18 ± 0.95 3.35± 0.61 2.35 ± 0.70
70-79 Male 21 3.71 ± 0.78 2.14 ± 0.73** 2.24 ± 0.89** 2.00 ± 0.89* 3.19 ± 1.40 3.57± 0.75 2.10 ± 1.04
Female 9 3.44 ± 0.88 2.33 ± 1.00** 2.33 ± 1.00** 2.22 ± 0.83** 2.78 ± 1.39 3.44± 0.73 2.78 ± 0.83
Patients with
severe COPD
50-59 Male 16 4.06 ± 1.12** 2.13 ± 1.09 2.69 ± 1.25* 2.44 ± 1.36** 3.25 ± 1.00 3.56 ± 0.96* 2.50 ± 1.21
Female 4 4.25 ± 0.65 3.25 ± 0.50** 4.00 ± 0.00** 4.00 ± 0.00** 4.00 ± 0.00** 4.00 ± 0.00 3.75 ± 0.50*
60-69 Male 29 4.00 ± 1.10** 2.41 ± 1.12** 2.90 ±1.21** 2.79 ± 1.18** 3.14 ± 1.16 3.90 ± 0.77** 3.03 ± 1.12**
Female 9 4.33 ± 0.71* 2.67 ± 1.32** 3.00 ± 1.41** 1.89 ± 1.05** 3.67 ± 0.71 4.22 ± 0.44** 3.22 ± 1.20*
70-79 Male 27 4.26 ± 0.94** 2.52 ± 1.25** 3.19 ± 1.14** 2.78 ± 1.34** 3.30 ± 1.38 4.04 ± 0.81** 2.78 ± 1.09**#
Female 14 4.50 ± 0.52 3.14 ± 1.10** 3.93 ± 1.14** 3.36 ± 1.35** 3.64 ± 1.01 3.86 ± 0.77 3.86 ± 0.86**
Data are expressed as mean ± SD.
*: P < 0.005, **: P < 0.001 vs. Healthy subjects.
# P < 0.005, Male vs. Female.
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tients and their doctors was > 0.527 in the Japanese
group, except for the “Pain” chart, and > 0.826 in the
Chinese group for all of the items.
The Japanese patients with COPD gave higher scores
on the “Pain” item than the doctor’s evaluation did, indi-
cating that the doctor had underestimated the pain the pa-
tients felt. This discrepancy may be due in part to
Japanese characteristics such as stoicism. The significant
correlations of the COOP/WONCA chart items with the
number of respiratory symptoms associated with COPD
and with COPD status support the external validity of the
charts. However, there were two aspects of the COOP/
WONCA charts that differed between the Japanese and
Chinese subjects. One was that there was no significant
correlation between “Pain” and the number of respiratory
symptoms of COPD in the Japanese group; the other was
that all of the items, except “Change in health”, showed
higher correlation with BI in the Chinese group than in
the Japanese group. Pain control may have been more
complete in Japanese patients with COPD than in Chinese
patients. The reasons for the low correlation between BI
and COOP/WONCA charts in the Japanese population
are not clear. Cigarette type, smoking habits, and the to-
bacco smoking environment surrounding the patient may
have contributed to these differences in the Japanese and
Chinese groups.
To clarify the determinants of the COOP/WONCA
chart items, we performed stepwise multiple regressions,
adjusting by nationality, age, sex, COPD status, number
of respiratory symptoms, and heating sources. The
COPD status, the number of respiratory symptoms, or
both were predictive variables for all of the items except
“Change of health”. This result suggests that the health
status measured by the COOP/WONCA charts reflected
the levels and conditions of COPD patients. In addition,
those scores on all items except “Feelings” and “Overall
health” could be compared between the Japanese and
Chinese populations according to the result from step-
wise multiple regression analyses. Although nationality
was a predictive variable for “Feelings” and “Overall
health”, the scores for “Feelings” among healthy subjects
were better in the Chinese group than in the Japanese
group, whereas for the COPD patients, the “Overall
health” score was better in the Japanese group than in
the Chinese group. The social environment surrounding
the patients, lifestyle, cultural and religious background,
and medical treatments may influence “Feelings” and
“Overall health” in complicated ways. It is necessary to
analyze this point in more detail. The reliability and val-
idity of the English version of the COOP/WONCA
charts has been tested with COPD patients. Stavem and
Jodalen [19] observed high correlation between items on
the COOP/WONCA charts and the EuroQol 5-Dimension (EQ-5D) test in 59 male and female outpa-
tients with COPD (average age 57 years old). The authors
suggested that the reliability of the COOP/WONCA items
was acceptable for use at the group level, but lower than
current recommendations for use in individual patients. In
contrast, Eaton et al. [17] found that the Dartmouth
COOP charts were reliable, valid, and responsive com-
pared with the SF-36, Chronic Respiratory Questionnaire
(CRQ), and Hospital Anxiety and Depression (HAD)
questionnaires in a comparative study of oxygen therapy
for patients with COPD, who were on average 68.3 years
old. The authors showed that these charts are a simple, re-
liable health-related quality-of-life tool that was valid and
responsive in their population of COPD patients and may
have a valuable role in routine clinical practice. Our results
also suggested that the Japanese and Chinese versions of
the COOP/WONCA charts provide good reliability and
validity for measuring health status and for comparing
healthy subjects and patients with COPD in Japanese and
Chinese populations.
Comparison of health status in Japanese and Chinese
patients with COPD by using COOP/WONCA charts
1. In our Japanese subjects, patients with COPD
showed almost the same health status as healthy
subjects of the same age, when stratified by sex, age,
and COPD status (Table 6). However, although the
healthy Chinese subjects had clearly higher health
status than the Japanese subjects, the health status
declined in proportion to GOLD stage in patients
with COPD. In particular, for Chinese subjects, the
physical score and daily and social activity scores
were worse in the patients with moderate COPD
than in the healthy subjects, and the pain and
psychological health status worsened further in the
patients with severe COPD. The poor “Overall
health” in the patients with severe COPD may
reflect the strong deterioration of physical and social
activity and psychological performance.
Few studies have used the COOP/WONCA charts to
evaluate chronic disease and health status in COPD pa-
tients and have compared the results between countries.
There is only one report that we know of that compared
the results of a factor analysis of COOP/WONCA charts
at primary care clinics in four countries and showed the
average scores on each item and the 95% confidence inter-
val [20]. The authors suggested that the COOP/WONCA
system was suitable for general use in primary care
internationally.
The present study clarified that although healthy
Chinese 50- to 79-year-olds have higher health status than
corresponding Japanese people, the health status of
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worse. Because a high positive correlation was observed
between indoor use of smoky fuels and “Daily activity”
and “Social activity” scores in the Chinese group, use
of these fuels may be one of the precipitating factors
of COPD in the Chinese population. More than 20% of
Chinese males and females in this study were using coal
or biomass indoors; indoor use of smoky fuels was associ-
ated with worse respiratory symptoms, which restrained
physical and social activity. Diette et al. [27] reviewed the
relation of biomass combustion exposure in an indoor en-
vironment and pulmonary obstructive disease, and found
that combustion of biomass or coal indoors can lead to a
fall in pulmonary function and aggravation of COPD.
Therefore, the use of indoor heating and cooking equip-
ment that does not produce smoke and the avoidance of
cigarette smoking may improve physical and social activity
and psychological levels as well as medical treatment, in-
cluding pain control. Future studies should analyze risk
factors related to health status in patients with COPD in
the Chinese population. Aging and air pollution are in-
creasing rapidly in Asia, which will likely increase the rate
of COPD disease and related mortality. Immediate action
to reduce risk factors leading to COPD may be required for
improving the health economic and social burdens caused
by the disability-adjusted life years lost due to COPD.
Conclusions
The Japanese and Chinese versions of the COOP/WONCA
charts showed good reliability and validity for measuring
health status and for comparing healthy subjects and pa-
tients with COPD in Japanese and Chinese populations.
The physical, psychosocial activities, and pain scores in-
creased significantly as COPD status worsened in Chinese
subjects, whereas these scores were not affected by sex,
age, or COPD status for Japanese subjects. Brinkman index
and indoor use of smoky fuel affected the COOP/WONCA
scores in Chinese patients but not in Japanese patients.
These results suggest that countermeasures against insuffi-
cient health care and smoky environments may improve
the health status of Chinese patients with COPD.
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